The APP Score: A simple serum biomarker model to enhance prognostic prediction in hepatocellular carcinoma-Reference-Cited by-同舟云学术

The APP Score: A simple serum biomarker model to enhance prognostic prediction in hepatocellular carcinoma

Published:2024-12-31 Issue:6 Volume:18 Page:567-583
ISSN:1881-7815
Container-title:BioScience Trends
language:en
Short-container-title:BST

Author:

Zhang Jinyu¹²,Wu Qionglan¹²,Zeng Jinhua¹²,Zeng Yongyi¹²,Liu Jingfeng¹²,Zeng Jianxing¹²

Affiliation:

1. Department of Hepatobiliary Surgery, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, Fujian, China.

2. Hepatobiliary Medical Center of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, Fujian, China.

Publisher

International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)

Link

https://www.jstage.jst.go.jp/article/bst/18/6/18_2024.01228/_pdf

Reference30 articles.

1. 1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018; 68:394-424.

2. 2. Llovet JM, Zucman-Rossi J, Pikarsky E, Sangro B, Schwartz M, Sherman M, Gores G. Hepatocellular carcinoma. Nat Rev Dis Primers. 2016; 2:16018.

3. 3. Chun YS, Pawlik TM, Vauthey JN. 8th Edition of the AJCC Cancer Staging Manual: Pancreas and hepatobiliary cancers. Ann Surg Oncol. 2018; 25:845-847.

4. 4. Zhou J, Sun HC, Wang Z, et al. Guidelines for diagnosis and treatment of primary liver cancer in China (2017 Edition). Liver Cancer. 2018; 7:235-260.

5. 5. European Association for the Study of the Liver. EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma. J Hepatol. 2018; 69:182-236.